More on LRMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+42.6% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Larimar Therapeutics (NQ:LRMR)
Delayed: 2.35 +0.08 (3.52%)
Prev. Close $2.27  
Open$2.27 
52 Wk High$ 
52 Wk Low$ 
Day High$2.37 
Day Low$2.22 
P/E N/A  
EPS$ 
Volume1,143,990 

Friends, Peers and Foes (?): IPSC, KBLB, META, MVRS, VIR (more...)

Oct 1, 2026 04:27 PM Form 4 Larimar Therapeutics, For: Sep 29 Filed by: Harlow John B. Jr.
Oct 1, 2026 04:27 PM Form 3 Larimar Therapeutics, For: Sep 29 Filed by: Harlow John B. Jr.
Sep 29, 2026 04:07 PM Form 8-K Larimar Therapeutics, For: Sep 29
Sep 29, 2026 04:05 PM Larimar Therapeutics names John Harlow as president and COO
Sep 29, 2026 04:05 PM Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
Sep 14, 2026 06:06 AM Leerink Starts Larimar Therapeutics (LRMR) at Outperform
Sep 9, 2026 04:05 PM Century Therapeutics names Joseph Truitt to its board of directors
Sep 9, 2026 04:05 PM Century Therapeutics Appoints Joseph Truitt to Board of Directors
Aug 4, 2026 07:24 AM Larimar Therapeutics, Inc. (LRMR) Tops Q2 EPS by 8c
Aug 4, 2026 07:12 AM Form 10-Q Larimar Therapeutics, For: Jun 30
View All Articles

Entities mentioned with LRMR

View All Entities